OQROGet OQRO Pro
Insider trade

Biogen (BIIB)Director sold ~$119K

Lloyd Minor, Director at Biogen, sold ~$119K of Biogen shares.

~$119K
Approx. value · 593 sh @ $200.96
2,689
Holds after · shares reported
Traded
Aug 4, 2026
Filed
Aug 5, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 27, 2026CongressDisclosed purchase of BIIB — reported range $1,001 - $15,000
  2. May 11, 2026Congress · 1 personMembers of Congress: 2 purchases
  3. May 12, 2026CongressDisclosed purchase of BIIB — reported range $1,001 - $15,000
  4. Jun 2, 2026CongressDisclosed sale of BIIB — reported range $15,001 - $50,000
  5. Jun 5, 20265% stakeFMR LLC reported a passive stake (13G) of 11.3%
  6. Jun 5, 2026CongressDisclosed purchase of BIIB — reported range $1,001 - $15,000
  7. Jul 1, 2026Company filing · Form 8-K · ResultsReported its results
  8. Jul 23, 2026Government · Federal Register noticeAdvisory Committee; Peripheral and Central Nervous System Drugs Advisory Committee; Termination and Reestablishment
  9. Jul 29, 2026Company filing · Form 8-K · ResultsReported its results
  10. Aug 3, 2026InsiderDirector sold ~$121K of BIIB shares in the open market
  11. Aug 4, 2026 · this disclosureInsiderDirector sold ~$119K of BIIB shares in the open market

What came next

  1. Aug 6, 20265% stakeFMR LLC reported a passive stake (13G) of 12.4%
  2. Aug 18, 2026CongressDisclosed sale of BIIB — reported range $1,001 - $15,000
  3. Sep 17, 2026Government · Federal Register noticeGranting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules
  4. Sep 24, 2026CongressDisclosed partial sale of BIIB — reported range $1,001 - $15,000
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Biogen

For Biogen, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 11 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BIIB page.

Other recent filings by Lloyd Minor, Director

The full history of Lloyd Minor, Director is on the profile page.

How this filing works

Other disclosures at Biogen

Everything OQRO holds on this company is on its BIIB page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data